GEVO

Gevo, Inc. Basic Materials - Specialty Chemicals Investor Relations →

NO
27.4% ABOVE
↑ Moving away Was 12.8% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $1.59
14-Week RSI 47
Rel. Volume (14w) This week's trading vs. the 14-week average 0.8x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.19

Gevo, Inc. (GEVO) closed at $2.03 as of 2026-05-01, trading 27.4% above its 200-week moving average of $1.59. The stock moved further from the line this week, up from 12.8% last week. The 14-week RSI sits at 47, indicating neutral momentum.

Trading volume is running at 0.8x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.19 ratio) is neutral — neither side is clearly dominating.

Over the past 746 weeks of data, GEVO has crossed below its 200-week moving average 4 times. On average, these episodes lasted 162 weeks. The average one-year return after crossing below was -54.7%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $493 million, GEVO is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -6.8%. The stock trades at 1.0x book value.

Share count has increased 2.2% over three years, indicating dilution.

Over the past 14.3 years, a hypothetical investment of $100 in GEVO would have grown to $0, compared to $703 for the S&P 500. GEVO has returned -51.2% annualized vs 14.6% for the index, underperforming the broader market over this period.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: GEVO vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After GEVO Crosses Below the Line?

Across 4 historical episodes, buying GEVO when it crossed below its 200-week moving average produced an average return of -52.5% after 12 months (median -36.0%), compared to +7.8% for the S&P 500 over the same periods. After 24 months, the average return was -80.0% vs +33.2% for the index.

Each line shows $100 invested at the moment GEVO crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

GEVO has crossed below its 200-week MA 4 times with an average 1-year return of +-54.7% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Jan 2012Jan 202146999.5%-68.1%-100.0%
Jan 2022Mar 2022720.9%-37.7%-38.3%
May 2022May 202211.4%-68.1%-43.6%
Jun 2022Sep 202517183.6%-45.0%-28.0%
Average162+-54.7%

Frequently Asked Questions

Is GEVO below its 200-week moving average?

No. Gevo, Inc. (GEVO) is currently 27.4% above its 200-week moving average of $1.59. It would need to fall to $1.59 to cross below the line.

What is GEVO's 200-week moving average price?

Gevo, Inc.'s 200-week moving average is $1.59 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when GEVO drops below its 200-week moving average?

GEVO has crossed below its 200-week moving average 4 times in our data. The average one-year return after these crossings was -54.7%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 162 weeks on average.

Is GEVO a good value right now?

Here's what our data says about GEVO as of 2026-05-01: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 47. Free cash flow is currently negative. Return on equity is -6.8%. Price-to-book is 1.0x. This is not a buy or sell recommendation — always do your own research.

How does GEVO compare to the S&P 500?

Over the past 14.3 years, $100 invested in GEVO would have grown to $0, compared to $703 for the S&P 500. That's -51.2% annualized vs 14.6% for the index. GEVO has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-05-01